S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in

NASDAQ:CPHD - Cepheid Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume1.25 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
Current SymbolNASDAQ:CPHD
CUSIP15670R10
Phone+1-408-5414191

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CPHD News and Ratings via Email

Sign-up to receive the latest news and ratings for CPHD and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


Your 401(k) or IRA account could be in double-trouble in 2020! With a slowing global economy and the uncertainty of a national election looming, it's time to PLAY DEFENSE with your hard-earned money. Employ a winning strategy for wealth protection and portfolio diversification to avoid the coming rush of economic risk.

Cepheid (NASDAQ:CPHD) Frequently Asked Questions

What is Cepheid's stock symbol?

Cepheid trades on the NASDAQ under the ticker symbol "CPHD."

How were Cepheid's earnings last quarter?

Cepheid (NASDAQ:CPHD) released its earnings results on Thursday, July, 28th. The scientific and technical instruments company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.19. The scientific and technical instruments company earned $146 million during the quarter, compared to analyst estimates of $145.82 million. Cepheid's quarterly revenue was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.06) EPS. View Cepheid's Earnings History.

Has Cepheid been receiving favorable news coverage?

Media stories about CPHD stock have trended somewhat positive on Monday, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cepheid earned a coverage optimism score of 1.7 on InfoTrie's scale. They also gave news stories about the scientific and technical instruments company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Cepheid.

Who are some of Cepheid's key competitors?

What other stocks do shareholders of Cepheid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cepheid investors own include Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), Alibaba Group (BABA), Wells Fargo & Co (WFC), Celgene (CELG), Gilead Sciences (GILD), GenMark Diagnostics (GNMK), Intercept Pharmaceuticals (ICPT) and Illumina (ILMN).

What is Cepheid's official website?

The official website for Cepheid is http://www.cepheid.com/.

How can I contact Cepheid?

Cepheid's mailing address is 904 E Caribbean Dr, SUNNYVALE, CA 94089-1189, United States. The scientific and technical instruments company can be reached via phone at +1-408-5414191.


MarketBeat Community Rating for Cepheid (NASDAQ CPHD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  521 (Vote Outperform)
Underperform Votes:  502 (Vote Underperform)
Total Votes:  1,023
MarketBeat's community ratings are surveys of what our community members think about Cepheid and other stocks. Vote "Outperform" if you believe CPHD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPHD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel